JPH0354104B2 - - Google Patents
Info
- Publication number
- JPH0354104B2 JPH0354104B2 JP57089528A JP8952882A JPH0354104B2 JP H0354104 B2 JPH0354104 B2 JP H0354104B2 JP 57089528 A JP57089528 A JP 57089528A JP 8952882 A JP8952882 A JP 8952882A JP H0354104 B2 JPH0354104 B2 JP H0354104B2
- Authority
- JP
- Japan
- Prior art keywords
- antibiotic
- culture
- methanol
- streptomyces
- chloroform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- WZZGVUSWZMBPPL-UHFFFAOYSA-N Diazaquinomycin A Chemical compound N1C(=O)C(C)=C(CCC)C2=C1C(=O)C(NC(=O)C(C)=C1CCC)=C1C2=O WZZGVUSWZMBPPL-UHFFFAOYSA-N 0.000 claims description 21
- 230000003115 biocidal effect Effects 0.000 claims description 13
- 244000005700 microbiome Species 0.000 claims description 8
- 241000187747 Streptomyces Species 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 241000187180 Streptomyces sp. Species 0.000 claims description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 6
- 108010080698 Peptones Proteins 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 235000019319 peptone Nutrition 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 3
- 241000194031 Enterococcus faecium Species 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000013058 crude material Substances 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 229910052805 deuterium Inorganic materials 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 235000019646 color tone Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 1
- 235000008191 folinic acid Nutrition 0.000 description 1
- 239000011672 folinic acid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001691 leucovorin Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
本発明は、新規抗生物質OM−704−Aおよび
その製造方法に関する。
本発明は、ある種の放線菌が新規抗生物質を生
産する能力を有するという知見に基いている。
本発明の目的は、本発明者によつてOM−704
−Aと命名された新規抗生物質およびその製造方
法を提供することにある。
本発明により、次式で表される抗生物質OM−
704−Aが提供される。
本抗生物質の理化学的性質は次の通りである。
(1) 元素分析値(%):
O H N
実施値 68.19 6.24 7.93
理論値 67.78 6.26 7.91
(2) 分子量:
マススペクトル(EIマススペクトル及びFD
マススペクトル)分析において、質量数354に
イオンピークが観測された。
以上の結果および元素分析値より分子式
C26H22N2O4が与えられた。
(3) 融点:293±2℃
(4) 比旋光度:本物質は難溶性であるため、一定
の測定値を与えない。
(5) 紫外線吸収スペクトル:
(メタノール中で測定)第1図のとおり。
吸収極大(nm)は次のとおり(カツコ内は
分子吸光係数)
250(11800,肩),260(13600,肩),
278(20100,肩),286(21700),
309(9760),321(8950),367(4130),
490(1150)
(6) 赤外線吸収スペクトル:(KBr法)第2図の
とおり。
cm-1 2960,1670,1625,1535,1470,1350,
1300
(7) プロトン核磁気共鳴スペクトル:
(重クロロホルム/重メタノール中で測定)第
3図のとおり。
(8) 溶剤に対する溶解性:クロロホルム、ジオキ
サン、メタノール、ジメチルホルムアミドにわ
ずかに溶け、水に不溶である。
(9) 塩基性、中性、酸性の区分:中性物質。
(10) 物質の色:赤橙色。
(11) Rf値:シリカゲル薄層クロマトグラフイー
(メルク社、TLCアルミシート、シリカゲル
60F254、厚さ0.2mm)を常法により行つたとき
のRf値は、次のとおりである。
(i) クロロホルム/メタノール(9:1) 0.45
(ii) ベンゼン/メタノール(4:1) 0.58
以上の理化学的性質およびメチル体の性質か
ら、本抗生物質は前記の式で表される構造を持
つと認められる。
本化合物は抗生物質で、その生物学的性質は次
のとおりである。
(1) 抗菌性
寒天希釈法による最小阻止濃度(MIC)は、
第1表に示す通りである。
The present invention relates to a novel antibiotic OM-704-A and a method for producing the same. The present invention is based on the finding that certain actinomycetes have the ability to produce novel antibiotics. The purpose of the present invention is to provide the OM-704
An object of the present invention is to provide a novel antibiotic named -A and a method for producing the same. According to the present invention, an antibiotic OM-
704-A is provided. The physicochemical properties of this antibiotic are as follows. (1) Elemental analysis value (%): O H N Actual value 68.19 6.24 7.93 Theoretical value 67.78 6.26 7.91 (2) Molecular weight: Mass spectrum (EI mass spectrum and FD
In mass spectrum analysis, an ion peak was observed at mass number 354. From the above results and elemental analysis values, the molecular formula C 26 H 22 N 2 O 4 was given. (3) Melting point: 293±2℃ (4) Specific optical rotation: This substance is poorly soluble, so it does not give a constant measured value. (5) Ultraviolet absorption spectrum: (Measured in methanol) As shown in Figure 1. The absorption maximum (nm) is as follows (molecular extinction coefficient is in the box): 250 (11800, shoulder), 260 (13600, shoulder), 278 (20100, shoulder), 286 (21700), 309 (9760), 321 ( 8950), 367 (4130), 490 (1150) (6) Infrared absorption spectrum: (KBr method) as shown in Figure 2. cm -1 2960, 1670, 1625, 1535, 1470, 1350,
1300 (7) Proton nuclear magnetic resonance spectrum: (measured in deuterium chloroform/deuterium methanol) as shown in Figure 3. (8) Solubility in solvents: Slightly soluble in chloroform, dioxane, methanol, and dimethylformamide, and insoluble in water. (9) Classification of basic, neutral, and acidic: Neutral substances. (10) Color of substance: red-orange. (11) Rf value: Silica gel thin layer chromatography (Merck, TLC aluminum sheet, silica gel
60F 254 , thickness 0.2mm) by the usual method, the Rf value is as follows. (i) Chloroform/methanol (9:1) 0.45 (ii) Benzene/methanol (4:1) 0.58 Based on the above physical and chemical properties and the properties of the methyl form, this antibiotic has the structure represented by the above formula. It is recognized that This compound is an antibiotic and its biological properties are as follows. (1) Antibacterial properties The minimum inhibitory concentration (MIC) determined by the agar dilution method is
As shown in Table 1.
【表】
以上のように、本抗生物質OM−704−Aは
グラム陽性細菌に対して活性を示す。本抗生物
質のLD50は100mg/Kg(マウス腹腔内投与)で
ある。従つて本抗生物質は抗菌剤としてこれら
の細菌に起因するヒト、動物、又は植物の疾病
の予防あるいは治療に用いられることが期待さ
れる。
上記の理化学的及び生物学的性質を既知抗生物
質と比較した結果、既知抗生物質に該当するもの
がなく、ストレプトコツカス・フエシユウム
IFO3181に対する抗菌活性がチミジン、ロイコボ
リン又はジヒドロ葉酸の添加により回復されるこ
とから、抗生物質OM−704−Aは新規な抗生物
質であることがわかつた。
本発明による抗生物質OM−704−Aの製造方
法は、ストレプトミセス属に属し、抗生物質OM
−704−A産生能をもつ微生物を培地に好気的に
培養し、培養物中に所望の化合物を蓄積させ、培
養物から抗生物質合物OM−704−Aを回収する
工程からなつている。
ストレプトミセス属に属し、かつ抗生物質OM
−704−A産生能を有するかぎり、どのような微
生物も本発明の目的に用いることができる。実施
例に記載された菌株は、本発明者によつて新たに
土壌より分離されたストレプトミセス・エスピ
−・(Streptomyces sp.)OM−704−KA333株で
あるが、抗生物質OM−704−A産生能を有する
かぎり、この菌株から自然的又は人工的誘導によ
つて産生された変異株も、本発明の目的に用いる
ことができる。
上記の菌株ストレプトミセス・エスピー・OM
−704−KA333株は、工業技術院微生物工業技術
研究所に微工研菌寄第6520号として寄託されてい
る。その菌学的性状は次のとおりである。
() 形態的性質
栄養菌糸は天然培地、合成培地の両方でよく
発達し、通常は隔壁を有しない。気菌糸は、ペ
プトン・イースト鉄寒天以外の培地では中程度
あるいは豊富に着生し、ビロード状で、白色か
ら薄桃色を呈する。顕微鏡下の観察では、胞子
柄は直線状を呈し、10個以上の胞子の連鎖が認
められる。胞子の大きさは0.57×1.0μmで円柱
状であり、胞子の表面は平滑である。菌核、胞
子嚢及び遊走子は見出されない。
() 各種培地上での性状
イー・ビー・シヤーリング(Int.J.Syst.
Bacteriol.16巻、313頁、1966年)の方法に従
い、使用した培地及び試験方法は公知である。
結果を第2表に示す。色調は標準色としてカラ
ー・ハーモニー・マニユアル第4版(コンテナ
ー・コーポレーシヨン・オブ・アメリカ・シカ
ゴ、1958年)を用いて決定し、色表名とともに
括弧内にそのコードを併記した。以下において
特記しないかぎり、27℃、2週間目の各培地に
おける観察である。[Table] As described above, this antibiotic OM-704-A shows activity against Gram-positive bacteria. The LD 50 of this antibiotic is 100 mg/Kg (intraperitoneal administration in mice). Therefore, the present antibiotic is expected to be used as an antibacterial agent for the prevention or treatment of human, animal, or plant diseases caused by these bacteria. As a result of comparing the above physicochemical and biological properties with known antibiotics, there were no known antibiotics, and Streptococcus faecium
Antibiotic OM-704-A was found to be a novel antibiotic since the antibacterial activity against IFO3181 was restored by the addition of thymidine, leucovorin or dihydrofolic acid. The method for producing antibiotic OM-704-A according to the present invention is directed to the production of antibiotic OM-704-A, which belongs to the genus Streptomyces.
-704-A-producing microorganisms are aerobically cultured in a medium, the desired compound is accumulated in the culture, and the antibiotic compound OM-704-A is recovered from the culture. . Belongs to the genus Streptomyces and is an antibiotic OM
Any microorganism can be used for the purpose of the present invention as long as it has the ability to produce -704-A. The bacterial strain described in the Examples is Streptomyces sp. OM-704-KA333 strain, which was newly isolated from soil by the present inventor. Mutant strains produced from this strain by natural or artificial induction can also be used for the purpose of the present invention, as long as they have production ability. The above strains Streptomyces sp. OM
Strain -704-KA333 has been deposited with the Institute of Microbiology, Agency of Industrial Science and Technology as Microbiology Research Institute No. 6520. Its mycological properties are as follows. () Morphological properties Vegetative hyphae develop well in both natural and synthetic media and usually do not have septa. Aerial mycelium grows moderately or abundantly on media other than peptone yeast iron agar, and is velvety and white to pale pink in color. When observed under a microscope, the sporophyte appears linear and chains of 10 or more spores are observed. The size of the spore is 0.57 x 1.0 μm, cylindrical, and the surface of the spore is smooth. No sclerotia, sporangia and zoospores are found. () Properties on various media E.B. Shearing (Int.J.Syst.
Bacteriol. Vol. 16, p. 313, 1966), and the culture medium and test method used are known.
The results are shown in Table 2. The color tones were determined using the Color Harmony Manual, 4th edition (Container Corporation of America, Chicago, 1958) as standard colors, and the code was written in parentheses along with the color table name. Unless otherwise specified below, observations were made on each medium at 27°C for 2 weeks.
【表】【table】
【表】【table】
【表】
セス・プロジエクト選定の培地
() 生理的諸性質
(1) メラニン色素の形成
(イ) チロシン寒天 陰性
(ロ) ペプトン・イースト鉄寒天 陰性
(ハ) グルコース・ペプトン・ゼラ
チン培地(穿刺21〜23℃) 陽性
(ニ) トリプトン・イースト液 陰性
(2) チロシナーゼ反応 陰性
(3) 硝酸塩の還元 陰性
(4) 硫化水素の生産 陰性
(5) ゼラチンの液化(グルコース・ペプトン・
ゼラチン培地) 陽性
(6) スターチの加水分解 陽性
(7) 脱脂乳の凝固(37℃) 陽性
(8) 脱脂乳のペプトン化(37℃) 陽性
(9) 生育温度範囲 15℃〜40℃
(10) 炭素源の利用性
(プリドハム・ゴドリーブ寒天培地)
利用する:D−グルコース・D−キシロー
ス、D−マンニトール、D−フラクトース
やや利用する:Lアラビノース、i−イノ
シトール
利用しない:ラフイノース、シユクロー
ス、メリビオース
(11) セルロースの分解 陰性
() 細胞壁組成
デイアミノピメリン酸はLL−型であり、ア
ラビノース、ガラクトースは認られない。
以上、本菌の菌学的性状を要約すると次のと
おりである。
細胞壁組成はLL−デイアミノピメリン酸を
有する。また形態的には直線状の胞子鎖を形成
し、胞子の表面は平滑である。培養上の諸性質
は、栄養菌糸は淡紅色あるいは淡黄色を呈し、
気菌糸は白色あるいは薄桃色の色調を呈する。
可溶性色素はわずかに黄褐色の色素を生産し、
メラニン色素はグルコース・ペプトン・ゼラチ
ン培地のみで生産する。
これらの結果から、本菌株はストレプトミセ
ス属する菌種であり、プリドハムとトレスナー
の分類(バージス・マニユアル・オブ・デタミ
ネーテイブ・バクテリオロジー第8版、1974
年、748〜829頁)による、ホワイトあるいはレ
ツドシリーズに属する菌種と考えられる。
本発明の方法において、抗生物質OM−704−
Aを生産する微生物を培養する培地としては、ス
トレプトミセス属微生物の培養に常用される炭素
源、窒素源、無機物を含む各種の培地を使用する
ことができる。培地の炭素源の例はブドウ糖、麦
芽糖、乳糖、シヨ糖、デンプン、デキストリン、
グリセリン、糖蜜などであり、窒素源の例は大豆
粉、コーン・スチープ・リカー、綿実粉、ペプト
ン、肉エキス、乾燥酵母、カゼイン加水分解物、
アンモニウム塩、硝酸塩などである。無機物の例
はリン酸塩、マグネシウム、カリウム、カルシウ
ム、ナトリウム、鉄、マンガンなどの塩類であ
る。
培養は通常好気的に行なわれ、通気撹拌培養が
好適である。培養温度は微生物が発育し、抗生物
質OM−704−Aを生産する範囲で適宜変更でき
るが、好ましいのは25〜30℃である。PHは6〜7
が好ましい。培養時間は種々の条件によつて異な
るが、通常30〜100時間程度で、培養物中に蓄積
される抗生物質OM−704−Aが最高力価に達す
る。
培養終了後、培養物からの抗生物質OM−704
−Aの回収は、微生物の培養物より前述の理化学
的性状を有する抗生物質を分離精製する公知の手
段を単独または組合わせて行なうことができる。
実用的な分離精製法の一例を示すと次のとおりで
ある。
培養物を菌体と濾液とに分別する。菌体をアセ
トン又はメタノールで抽出し、その抽出液を濃縮
した後、酢酸エチル、クロロホルム等の有機溶媒
で抽出する。濾液からは、酢酸エチル、ベンゼン
等の水と分離し、抗生物質OM−704−Aを溶解
する有機溶媒で抽出した後、脂溶性物質の精製に
おいて通常用いられる公知の方法により、抗生物
質OM−704−Aを回収する。例えば、抽出液
(酢酸エチル層)を減圧下で濃縮し、生じた沈殿
を分離し、これをn−ヘキサンで洗浄した後、シ
リカゲルカラムクロマトグラフイーにより、溶出
溶媒としてクロロホルム、メタノールの混合溶媒
系を用いて、抗生物質OM−704−Aを単離する。
なお、生産される抗生物質OM−704−Aの検
出及び定量は、シリカゲル薄層クロマトグラフイ
ー(メルク社製、シリカゲル60F254、厚さ0.2mm、
展開溶媒;クロロホルム/メタノール=9:1、
抗生物質OM−704−AのRf値0.45)及びストレ
プトコツカス・フエシウム(Streptococcus
faecium)IFO3181を試験菌とするペーパーデイ
スク法により行なう。
次に本発明による抗生物質OM−704−Aの実
施例を示すが、この実施例は単なる一例を示すも
のであつて、本発明を限定するものではない。
実施例
ストレプトミセス・エスピー・
(Streptomyces.sp)OM−704−KA333株、微工
研菌寄第6520号)の斜面培養から1白金耳を種培
地に接種し、27℃で2日間培養後、30容ジヤー
フアーメンター中の20の培地に1%の割合で接
種し、27℃で48時間、通気量10/分、撹拌
250r.p.m.の条件で通気撹拌培養を行なつた。
種培地の組成はグルコース1.0%、スターチ2.0
%、酵母エキス0.5%、ペプトン0.5%、炭酸カル
シウム0.4%、本培地の組成はグルコース0.5%、
コン・スチープ・リカー1.0%、オートミール1.0
%、フアーマメデイア1.0%、K2HPO40.5%、
MgSO4・7H2O0.05%、FeSO4・7H2O0.001%、
MnCl2・4H2O0.001%、ZnSO4・7H2O0.001%、
CuSO4・5H2O0.001%、CoCl2・2H2O0.001%で、
使用時にそれぞれPH7.0に調整した後、121℃で15
分間滅菌した。
培養液20をシヤープレスで遠心分離して
(10000r.p.m)菌体と培養上清に分別する。得ら
れた菌体に、60%アセトン溶液1.5を加え撹拌
抽出し、これを濾別して60%アセトン抽出液を得
た。この60%アセトン抽出液を減圧下500mlまで
濃縮し、酢酸エチル400mlを加えてよく撹拌し再
抽出を行なつた。ここで得られた酢酸抽出液を減
圧下で20mlまで濃縮し、室温で一晩放置した後、
生じた沈殿を濾別し、乾燥することにより、130
mgの粗物質を得た。
次に、培養上清に酢酸エチル12を加え、よく
撹拌した後、遠心分離により酢酸エチル層を分離
した。この酢酸エチル抽出液を減圧下500mlまで
濃縮し、室温で一晩放置した後、生じた沈殿を濾
別し、桃赤色の粗物質510mgを得た。
これら菌体と培養上清とから得た抗生物質OM
−704−Aを含む粗物質640mgをクロロホルム/メ
タノール(4:1)に溶解し、予めクロロホルム
で充填したシリカゲルカラム(メルク社製、キー
ゼルゲル60、20g)の上端に添加した。カラムを
順次クロロホルム(160ml)及びクロロホルム/
メタノール(20:1、400ml)の順で溶出し、15
mlずつ分画した。ここでクロロホルム/メタノー
ル(20:1)の混合溶媒による溶出で得られた活
性分画(分画No.4〜14、15ml/フラクシヨンチユ
ーブ)を減圧下で濃縮し、室温で一晩放置するこ
とにより粗結晶120mgを得た。これをクロロホル
ム/メタノールの混合溶媒で晶析することによ
り、抗生物質OM−704−Aの赤橙色針状結晶96
mgを得た。
このものの性質は、前記した理化学的性質及び
生物学的性質と一致した。[Table] Media selected by Seth Project
() Physiological properties (1) Formation of melanin pigment (a) Tyrosine agar negative (b) Peptone/yeast iron agar negative (c) Glucose/peptone/gelatin medium (puncture at 21-23°C) positive (d) Tryptone・Yeast solution negative (2) Tyrosinase reaction negative (3) Nitrate reduction negative (4) Hydrogen sulfide production negative (5) Gelatin liquefaction (glucose, peptone,
Gelatin medium) Positive (6) Hydrolysis of starch Positive (7) Coagulation of skim milk (37℃) Positive (8) Peptonization of skim milk (37℃) Positive (9) Growth temperature range 15℃~40℃ (10 ) Availability of carbon sources (Pridham-Godelib agar medium) Used: D-glucose, D-xylose, D-mannitol, D-fructose Slightly used: L-arabinose, i-inositol Not used: ruffinose, sucrose, melibiose ( 11) Decomposition of cellulose Negative () Cell wall composition Diaminopimelic acid is LL- type, and arabinose and galactose are not observed. The mycological properties of this bacterium are summarized as follows. The cell wall composition has LL-diaminopimelic acid. In terms of morphology, it forms linear spore chains, and the surface of the spores is smooth. Regarding the culture characteristics, the vegetative hyphae are pale pink or pale yellow;
Aerial mycelia are white or pale pink in color.
Soluble pigments produce slightly yellow-brown pigments,
Melanin pigment is produced only in glucose-peptone-gelatin medium. Based on these results, this bacterial strain belongs to Streptomyces and is classified according to Pridham and Tresner's classification (Burgess Manual of Determinative Bacteriology, 8th edition, 1974).
It is considered to be a species belonging to the White or Red series, according to the authors (2010, pp. 748-829). In the method of the present invention, antibiotic OM-704-
As a medium for culturing the microorganism that produces A, various media containing carbon sources, nitrogen sources, and inorganic substances that are commonly used for culturing Streptomyces microorganisms can be used. Examples of carbon sources for the culture medium are glucose, maltose, lactose, sucrose, starch, dextrin,
Examples of nitrogen sources are soybean flour, corn steep liquor, cottonseed flour, peptone, meat extract, dried yeast, casein hydrolyzate, etc.
Ammonium salts, nitrates, etc. Examples of inorganic substances are salts such as phosphate, magnesium, potassium, calcium, sodium, iron, manganese, etc. Cultivation is usually carried out aerobically, and aerated agitation culture is preferred. The culture temperature can be changed as appropriate within a range that allows microorganisms to grow and produce antibiotic OM-704-A, but is preferably 25 to 30°C. PH is 6-7
is preferred. Although the culture time varies depending on various conditions, the antibiotic OM-704-A accumulated in the culture usually reaches its maximum titer in about 30 to 100 hours. After completion of culture, antibiotic OM-704 from culture
-A can be recovered by known means for separating and purifying antibiotics having the above-mentioned physicochemical properties from a culture of microorganisms, either alone or in combination.
An example of a practical separation and purification method is as follows. The culture is separated into bacterial cells and filtrate. The bacterial cells are extracted with acetone or methanol, the extract is concentrated, and then extracted with an organic solvent such as ethyl acetate or chloroform. The filtrate is separated from water such as ethyl acetate and benzene, extracted with an organic solvent that dissolves antibiotic OM-704-A, and then extracted with antibiotic OM-704-A by a known method commonly used in the purification of fat-soluble substances. Collect 704-A. For example, the extract (ethyl acetate layer) is concentrated under reduced pressure, the resulting precipitate is separated, washed with n-hexane, and then subjected to silica gel column chromatography using a mixed solvent of chloroform and methanol as the elution solvent. is used to isolate antibiotic OM-704-A. The produced antibiotic OM-704-A was detected and quantified using silica gel thin layer chromatography (manufactured by Merck & Co., Ltd., silica gel 60F 254 , thickness 0.2 mm,
Developing solvent; chloroform/methanol = 9:1,
Rf value of antibiotic OM-704-A (0.45) and Streptococcus faecium (Rf value 0.45) and Streptococcus faecium
faecium) IFO3181 as the test bacterium. Next, an example of the antibiotic OM-704-A according to the present invention will be shown, but this example is merely an example and does not limit the present invention. Example Streptomyces sp.
(Streptomyces.sp) strain OM-704-KA333, Microtechnical Research Institute No. 6520) was inoculated into a seed medium, and after culturing at 27°C for 2 days, it was placed in a 30-volume jar fermenter. Inoculate 20 media at a rate of 1% and incubate at 27℃ for 48 hours with aeration rate of 10/min and agitation.
Aerated agitation culture was performed at 250 rpm. The composition of the seed medium is glucose 1.0%, starch 2.0%
%, yeast extract 0.5%, peptone 0.5%, calcium carbonate 0.4%, the composition of this medium is glucose 0.5%,
Con steep liquor 1.0%, oatmeal 1.0
%, Pharmamedia 1.0%, K 2 HPO 4 0.5%,
MgSO4・7H2O0.05 %, FeSO4・7H2O0.001 %,
MnCl2・4H2O0.001 %, ZnSO4・7H2O0.001 %,
CuSO4・5H2O0.001 %, CoCl2・2H2O0.001 %,
15 at 121℃ after adjusting to PH7.0 during use.
Sterilized for minutes. Culture solution 20 is centrifuged using a shear press (10,000 rpm) to separate bacterial cells and culture supernatant. To the obtained bacterial cells, 1.5 g of 60% acetone solution was added and extracted with stirring, and this was filtered to obtain a 60% acetone extract. This 60% acetone extract was concentrated to 500 ml under reduced pressure, 400 ml of ethyl acetate was added, and the mixture was thoroughly stirred and re-extracted. The acetic acid extract obtained here was concentrated to 20 ml under reduced pressure, left overnight at room temperature,
By filtering and drying the resulting precipitate, 130
mg of crude material was obtained. Next, ethyl acetate 12 was added to the culture supernatant, and after stirring well, the ethyl acetate layer was separated by centrifugation. This ethyl acetate extract was concentrated under reduced pressure to 500 ml, left overnight at room temperature, and the resulting precipitate was filtered off to obtain 510 mg of a pink-red crude material. Antibiotic OM obtained from these bacterial cells and culture supernatant
640 mg of the crude material containing -704-A was dissolved in chloroform/methanol (4:1) and added to the top of a silica gel column (Kieselgel 60, 20 g, manufactured by Merck & Co.) that had been previously filled with chloroform. Fill the column with chloroform (160 ml) and chloroform/
Elute with methanol (20:1, 400ml),
It was fractionated into ml portions. Here, the active fractions (fraction Nos. 4 to 14, 15 ml/fraction tube) obtained by elution with a mixed solvent of chloroform/methanol (20:1) are concentrated under reduced pressure and left overnight at room temperature. As a result, 120 mg of crude crystals were obtained. By crystallizing this with a mixed solvent of chloroform/methanol, red-orange needle crystals of antibiotic OM-704-A were obtained.
I got mg. The properties of this substance were consistent with the physicochemical and biological properties described above.
第1図は抗生物質OM−704−Aの紫外線吸収
スペクトル(メタノール中で測定)、第2図は赤
外線吸収スペクトル(KBr法)、第3図は核磁気
共鳴スペクトル(重クロロホルム/重メタノール
中で測定)を示す。
Figure 1 shows the ultraviolet absorption spectrum (measured in methanol) of the antibiotic OM-704-A, Figure 2 shows the infrared absorption spectrum (KBr method), and Figure 3 shows the nuclear magnetic resonance spectrum (measured in deuterium chloroform/dew methanol). measurement).
Claims (1)
抗生物質OM−704−A産生能をもつ微生物を培
地に好気的に培養し、培養物中に所望の化合物を
蓄積させ、培養物からこれを回収する工程からな
る抗生物質合物OM−704−Aの製造方法。 3 微生物がストレプトミセス・エスピ−・
(Streptomyces sp.)OM−704−KA333(微工研
菌寄第6520号)である特許請求の範囲第2項記載
の方法。[Claims] Antibiotic OM-704-A represented by the following formula: 2 A microorganism belonging to the genus Streptomyces and capable of producing the antibiotic OM-704-A expressed by the following formula is cultured aerobically in a medium, the desired compound is accumulated in the culture, and the desired compound is extracted from the culture. A method for producing antibiotic compound OM-704-A, which comprises the step of recovering OM-704-A. 3 The microorganism is Streptomyces sp.
(Streptomyces sp.) OM-704-KA333 (Feikoken Bibori No. 6520).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57089528A JPS58205497A (en) | 1982-05-26 | 1982-05-26 | Antibiotic om-704-a and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57089528A JPS58205497A (en) | 1982-05-26 | 1982-05-26 | Antibiotic om-704-a and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58205497A JPS58205497A (en) | 1983-11-30 |
JPH0354104B2 true JPH0354104B2 (en) | 1991-08-19 |
Family
ID=13973305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57089528A Granted JPS58205497A (en) | 1982-05-26 | 1982-05-26 | Antibiotic om-704-a and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58205497A (en) |
-
1982
- 1982-05-26 JP JP57089528A patent/JPS58205497A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS58205497A (en) | 1983-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4107297A (en) | Antibiotic compound | |
US4199514A (en) | Compound, frenolicin B which is useful as an antibiotic | |
JPH0213677B2 (en) | ||
JPS5948484A (en) | Antibiotic om-173alpha2 and beta2 substance and its preparation | |
JPH0354104B2 (en) | ||
CA2041237C (en) | Ucf1 compounds derivatives thereof and processes for their preparation | |
JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
JPS632266B2 (en) | ||
EP0050853B1 (en) | Polyprenyl ketone derivatives, a process for their preparation, a pharmaceutical preparation containing said derivative and the use of the same | |
EP0050961B1 (en) | Novel antibiotics, a process for producing the same, medical compositions containing the same, and a novel strain of the genus streptomyces for use in producing the same | |
JPH10114777A (en) | Antibiotic substance spiroximicin and its production | |
JPS59170092A (en) | Novel antibiotic, ss8201d and its preparation | |
US4010075A (en) | Process for producing 4-thiouracil | |
US4371617A (en) | Process for preparing thienamycin | |
US4287302A (en) | Microbiological modification of antibiotic A23187 esters | |
KR810000686B1 (en) | Process for the preparation of piperidine derivative | |
US4247703A (en) | Microbiological modification of antibiotic A23187 esters | |
JPS589690A (en) | Antibiotic am-5344-a1 and its preparation | |
JPH0631311B2 (en) | Antibiotics RK-1061A, RK-1061B, and RK-1061C and method for producing the same | |
JPS5918991B2 (en) | Antibiotic AM-2947 and its manufacturing method | |
JPH0359911B2 (en) | ||
JPS63246388A (en) | Antibiotic rs-44b and manufacture | |
JPH0637519B2 (en) | Novel antibiotic globopeptin and method for producing the same | |
JPH0359910B2 (en) | ||
JPH0448793B2 (en) |